NewLink Genetics Newswire

Comprehensive Real-Time News Feed for NewLink Genetics.

Results 1 - 20 of 74 in NewLink Genetics

  1. Wall Street Fundamentals Releases New In-Depth Stock Reports on ALNY, ...Read the original story

    Friday Apr 11 | BayStreet.ca

    ... Pharmaceutical and access to the free equity report can be found at: www.WallStreetFundamentals.com/LJPC NewLink Genetics Corp. (NASDAQ: NLNK) shares traded in the range of $22.39 to $25.21 Thursday before settling to close at $22.51, a decrease of ...

    Comment?

  2. Mid-Morning Market Update: Markets Drop; Family Dollar Plans To Close 370 StoresRead the original story w/Photo

    Thursday Apr 10 | Benzinga

    ... percent. Top decliners in the sector included Sunesis Pharmaceuticals (NASDAQ: SNSS ), off 5.6 percent, and NewLink Genetics (NASDAQ: NLNK ), down 6.3 percent. Top Headline Family Dollar Stores (NYSE: FDO ) reported a drop in its fiscal ...

    Comment?

  3. NewLink Genetics Presents Data At American Association for Cancer Research 2014 Annual MeetingRead the original story

    Thursday Apr 10 | BioSpace

    NewLink Genetics Corporation , a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, presented preclinical data related to the immunostimulatory and anti-tumor effects of its two clinical-stage checkpoint inhibitors targeting the IDO ... (more)

    Comment?

  4. NewLink Genetics Presents Data at the AACR 2014 Annual MeetingRead the original story

    Wednesday Apr 9 | Freshnews

    04/09/14 -- NewLink Genetics Corporation (NASDAQ: NLNK), a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, presented preclinical data ...

    Comment?

  5. Eli Lilly and Company And Announce Research Collaboration To Inform...Read the original story

    Wednesday Apr 9 | BioSpace

    NewLink Genetics Corporation , a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, presented preclinical data related to the immunostimulatory and anti-tumor effects of its two clinical-stage checkpoint inhibitors targeting the IDO ... (more)

    Comment?

  6. NewLink Genetics Corp Price Target Increased to $45.00 by Analysts at MLV & Co.Read the original story

    Monday Mar 31 | AmericanBankingNews.com

    ... & Co. 's price target indicates a potential upside of 58.45% from the company's current price. Shares of NewLink Genetics Corp ( NASDAQ:NLNK ) traded up 9.95% during mid-day trading on Monday, hitting $28.40. 501,271 shares of the company's stock ...

    Comment?

  7. These Stocks Are Getting Hit Hardest During March's Biotech 'Correction'Read the original story

    Tuesday Mar 25 | TheStreet.com

    ... craze, so perhaps the selling we're seeing here is an unwinding of a biotech buzzword trade. Next: NewLink Genetics both down 37% in March. NewLink is another over-valued cancer buzzword stock which is finally reverting back to the mean. Raptor is ...

    Comment?

  8. NewLink Genetics management to meet with JMP SecuritiesRead the original story

    Mar 11, 2014 | Theflyonthewall.com

    NewLink Genetics reports Q4 EPS , consensus Reports Q4 revenue $294,000, consensus $310,000.

    Comment?

  9. NewLink Genetics Reports Fourth Quarter And Year End 2013 Financial ResultsRead the original story

    Mar 12, 2014 | BioSpace

    NewLink Genetics Corporation , today reported consolidated financial results for the fourth quarter and year end 2013 and reviewed key 2013 accomplishments.

    Comment?

  10. NewLink Genetics weakness creates buying opportunity, says CantorRead the original story

    Mar 3, 2014 | Theflyonthewall.com

    NewLink Genetics reports Q4 EPS , consensus Reports Q4 revenue $294,000, consensus $310,000.

    Comment?

  11. NewLink Genetics Corporation Reports Fourth Quarter and Year End 2013 Financial ResultsRead the original story

    Mar 11, 2014 | Freshnews

    03/11/14 -- NewLink Genetics Corporation (NASDAQ: NLNK), today reported consolidated financial results for the fourth quarter and year end 2013 and reviewed key 2013 accomplishments. "We achieved a major milestone in 2013 with the completion of ...

    Comment?

  12. NewLink Genetics' Independent Review Committee Recommends Study...Read the original story

    Mar 10, 2014 | BioSpace

    NewLink Genetics Corporation , a biopharmaceutical company focused on discovering, developing and commercializing novel immunotherapeutics to improve treatment options for patients with cancer, today announced the continuation of the Phase 3 IMPRESS clinical study of algenpantucel-L for patients with surgically resected pancreatic cancer following ... (more)

    Comment?

  13. NewLink Genetics Corp. Downgraded by Robert W. Baird to NeutralRead the original story

    Mar 7, 2014 | AmericanBankingNews.com

    ... have also recently commented on NLNK. Analysts at Stifel Nicolaus raised their price target on shares of NewLink Genetics Corp. from $31.00 to $53.00 in a research note on Wednesday, January 22nd. They now have a "buy" rating on the stock. They ...

    Comment?

  14. Why Alpha Natural Resources, NewLink Genetics, and Furmanite Tumbled TodayRead the original story

    Mar 7, 2014 | The Motley Fool

    ... shares of other coal companies throughout the industry -- even ones that Goldman still has buy ratings on. NewLink Genetics (NLNK) plunged 16% after the biotech company's update on its algenpantucel-L pancreatic-cancer drug study failed to deliver ...

    Comment?

  15. Friday's ETF with Unusual Volume: IBBRead the original story

    Mar 7, 2014 | MarketNewsVideo

    ... aceuticals (NASDAQ: AGIO ) is the component faring the best Friday, higher by about 12.5% on the day, while Newlink Genetics (NASDAQ: NLNK ) is lagging other components of the iShares Nasdaq Biotechnology ETF, trading lower by about 12.4%.

    Comment?

  16. 's Top #PreMarket LosersRead the original story

    Mar 7, 2014 | Benzinga

    ... ) shares dropped 11.20% to $85.75 in pre-market trading after the company reported downbeat Q2 earnings. NewLink Genetics (NASDAQ: NLNK ) shares fell 7.14% to $35.00 in the pre-market trading after the company's independent review committee ...

    Comment?

  17. Morning Movers in Biotech: Gilead Sciences, NewLink Genetics Corp. and Novartis AGRead the original story

    Mar 7, 2014 | The Motley Fool

    ... to agree with my sentiment, as Gilead shares are currently up about 1% at the time of writing this article. NewLink Genetics continues its wild week NewLink Genetics are down by almost 10% in premarket this morning after announcing that an ...

    Comment?

  18. NewLink Genetics' Independent Review Committee Recommends Study...Read the original story

    Mar 7, 2014 | Market Wire

    ... data safety monitoring committee," said Dr. Nicholas N. Vahanian, President and Chief Medical Officer of NewLink Genetics. "Now, with the first interim analysis behind us, we look forward to continuing the study and to gathering additional, more ...

    Comment?

  19. Five Star Equities Issues New Research Reports on AKRX, CLDX, CTB and ...Read the original story

    Mar 4, 2014 | BayStreet.ca

    ... on Cooper Tire & Rubber and free access to the in-depth equity report at: www.FiveStarEquities.com/CTB NewLink Genetics Corp. (NASDAQ: NLNK) shares dropped 11.58 percent to close at $39.08 a share Monday. The stock traded between $38.30 and $42.64 ...

    Comment?

  20. Why NewLink Genetics Corp. Shares SwoonedRead the original story

    Mar 3, 2014 | The Motley Fool

    ... as 13% after receiving a downgrade. So what: Before the opening bell, research firm R.W. Baird downgraded NewLink Genetics to neutral from outperform solely on a valuation basis, while keeping its price target on the company unchanged at $40. Shares ...

    Comment?